Mark Ayers

Owner of A1 FINANCIAL USA - We offer funding to US Business owners, $5,000 to $500 million.

[Mark Ayers @A1FinancialUSA]

@Tradin19 Good job! You're making money already!

[Mark Ayers @A1FinancialUSA]

$TPST Congratulations to Tempest Therapeutics, they've announced a partnership with Roche, a $250 Billion pharma company. A buyout would seem imminent for their HIGHLY successful cancer drug amezalpat (TPST-1120). A $47 target was set by major analysts. Just $1.07/sh currently.

[Mark Ayers @A1FinancialUSA]

$ADTX We were just notified that Aditxt has $5.1m cash on hand. Dilution Tracker has corrected itself. That's almost $40/share in cash alone. Full company Evaluation at $17.6m. The share price is an insane $1.47, & tiny float of just 130K.
Don'e be an ostrich.

[Mark Ayers @A1FinancialUSA]

$ADTX $LQR Congratulations to 2 newcomers to our list of the 5 most undervalued Nasdaq stocks! #1 ADTX is showing signs already this morning of having the largest Short Squeeze of the year with its tiny 130K float: https://t.co/ChAUpMMP90

[Mark Ayers @A1FinancialUSA]

@jeffhub91060854 As I posted previously, they are held privately by Aegis, so its a non-issue. The next ER will display that.

[Mark Ayers @A1FinancialUSA]

$SBFM We have been in contact with our friends at Nora Pharma and have a requested a PR on the status of marketing for Niopeg. We also asked they request a Compliance PR from Sunshine for Monday.

[Mark Ayers @A1FinancialUSA]

@jeffhub91060854 They met the $1/share price, that was all they needed to do. You have to stop listening to Bear BS!

[Mark Ayers @A1FinancialUSA]

$SBFM Congratulations on officially regaining Nasdaq Compliance! Time to get you up to that $20 Book Value you hold.

[Mark Ayers @A1FinancialUSA]

@jeffhub91060854 No, there was no Nasdaq request of the kind- that's just bear BS. It was not illegal either, just more bear BS, and nothing, they have plenty of cash, Series B are held by Aegis. We're having good price action again today.

[Mark Ayers @A1FinancialUSA]

$SYTA The Stock Market is having an 80% off sale on a stock with a Verizon contract, and just approved for sale in India(1.35 billion people)...Finviz Book Value is $4.29, they have $3.13/sh in cash alone. Just 98 cents RIGHT NOW!

[Mark Ayers @A1FinancialUSA]

@PostingOften What does that mean "believe" in?...Believe he existed? Sure...Believe that he's the son of the Creator of the universe more than we are individually? No. Was he something more than a normal human? Yes. Those of you out there that know what I'm talking about, congrats.

[Mark Ayers @A1FinancialUSA]

@FoodPornPhotos ICONIC

[Mark Ayers @A1FinancialUSA]

@Shalley886 @Siddha12512 If you notice, it's not for the public, Just Ascendiant Cap. They terminated the March one at $30mill. Just like many companies do, they have collateral set up for placements. Its nothing to worry about.

[Mark Ayers @A1FinancialUSA]

Congrats to our new top 5 most undervalued Nasdaq stocks! We proudly welcome newcomers $ALLR and $SPRC to our list, joining SBFM, SYTA and MGOL:https://t.co/ChAUpMMP90

[Mark Ayers @A1FinancialUSA]

@kashbunker @Siddha12512 Not just shorting, but selling...Because many folks need cash in this lousy economy, and bears shorting because they're scum sucking evil pigs. Value will always win out in time, this is why we have Quarterly ER reports.

[Mark Ayers @A1FinancialUSA]

@kashbunker @Siddha12512 We wrote why, incredible upside with the Taurette late stage trial....current low price is only a great buying opportunity in our opinion. With NO dilution in sight, The company has 13.7 months of cash left.

[Mark Ayers @A1FinancialUSA]

@Siddha12512 They're at $2.17 right now, and FLUSH with 15.2 months of cash left...so no RS, nor dilution anywhere in sight.

[Mark Ayers @A1FinancialUSA]

@Siddha12512 Trading for 33 years, Sir, and I know their history. The past is the past. It takes money to make money. They have a CANCER winner in Stenoparib for all that money, time and work.

[Mark Ayers @A1FinancialUSA]

@Siddha12512 Laugh all you want, but how many stocks do you know that went from $1.78 to $2.52 in one day?...its resilient as can be, and has quite an opportunity in Europe. It is #5 btw.

[Mark Ayers @A1FinancialUSA]

@Siddha12512 Yes. QUITE. Do the math.

[Mark Ayers @A1FinancialUSA]

@MKataroyan How do you like this great After Hour action?
It's finally 40 days since RS, could explode like Soligenix, Galmed, and so many more have lately.